CHALLENGES FACED BY EMERGING BIOTECH COMPANIES IN GETTING NEW PRODUCTS TO MARKET

The biopharmaceutical industry has become increasingly complex. As more and more countries and investigator sites sign on for clinical trials, and patients become harder to find and retain, coordinating and running each study can be difficult and time-consuming. Even the smallest mistakes can have a big impact on trial timelines and patients. Knowledge of global compliance and customs requirements, shipping timelines, innovative packaging techniques and access to leading forecasting, simulation and real-time supply chain tracking, are all essential components, that when utilized correctly, deliver an optimized supply chain that balances risk with cost, patient and study needs.

During the presentations, we will discuss the challenges faced by the new and emerging biopharmaceutical companies, and how we can work in partnership with them.

-The benefits of maintaining control, compliance and visibility across the entire supply chain.

-Supply optimization encompasses all elements of clinical supply chain management through proactive and comprehensive strategic planning through execution.

-How full service global clinical supplies expertise can help speed up the process of getting the right medication to the right patient at the right time.

Mitigating risk from end-to-end, from molecule to medicine, can result in the early licensure of new drugs to market.